The Middle East and Africa Code of Promotional Practices in the Pharmaceutical Industry
Sand Salhout and
Clemens Bechter
Additional contact information
Sand Salhout: Dual Studies Business Administration Program, Faculty of Business and Economics, Al-Quds University, Abu Dis 20002, Palestine
Clemens Bechter: Thammasat Business School, Tha Prachan, Bangkok 10200, Thailand
Administrative Sciences, 2018, vol. 8, issue 3, 1-13
Abstract:
The pharmaceutical industry is known for investing heavily in promotions targeted at healthcare professionals (HCPs). Governments around the world try to regulate unwanted promotional practices in different ways. Where binding laws are in place in the U.S.A., European governments favor self-regulation. The purpose of this research is the evaluation of the Middle East and Africa Code of Promotional Practices (MEACPP) as a preliminary draft and its implications. Our paper fills a research gap by looking into the perceptions of the parties involved, analyzing their interests, and predicting possible outcomes. We used a mixed-method approach. Interviews were conducted with pharmaceutical companies and associations; while a questionnaire was administered to HCPs. Our findings suggest that all parties are in favor of more transparency. However, when it comes to disclosing the received financial support, the HCPs are hesitant. An estimated 20% would be willing to fully disclose their received benefits, which is in line with their European colleagues. Multinational pharmaceutical companies follow their own in-house standards and fear being at a competitive disadvantage when local companies can promote their drugs without any strings attached. MEA pharmaceutical companies do not see the potential benefits of analyzing the publicly available data to identify key opinion leaders (KOLs). The limitation of our research is the fact that the MEACPP has not been implemented yet and survey results are therefore based on expectations rather than real events.
Keywords: Middle East and Africa Code of Promotional Practices; pharmaceutical industry; transparency code; self-regulation (search for similar items in EconPapers)
JEL-codes: L M M0 M1 M10 M11 M12 M14 M15 M16 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.mdpi.com/2076-3387/8/3/53/pdf (application/pdf)
https://www.mdpi.com/2076-3387/8/3/53/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jadmsc:v:8:y:2018:i:3:p:53-:d:168924
Access Statistics for this article
Administrative Sciences is currently edited by Ms. Nancy Ma
More articles in Administrative Sciences from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().